These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37284701)

  • 1. Plasma UCHL1, GFAP, Tau, and NfL Are Not Different in Young Healthy Persons With Mild COVID-19 Symptoms Early in the Pandemic: A Pilot Study.
    Rogatzki MJ; Szeghy RE; Stute NL; Province VM; Augenreich MA; Stickford JL; Stickford ASL; Hanson ED; Ratchford SM
    Neurotrauma Rep; 2023; 4(1):330-341. PubMed ID: 37284701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma tau, NfL, GFAP and UCHL1 as candidate biomarkers of alcohol withdrawal-associated brain damage: A pilot study.
    Clergue-Duval V; Vrillon A; Jeanblanc J; Questel F; Azuar J; Fouquet G; Mouton-Liger F; Rollet D; Hispard E; Bouaziz-Amar E; Bloch V; Dereux A; Cognat E; Marie-Claire C; Laplanche JL; Bellivier F; Paquet C; Naassila M; Vorspan F
    Addict Biol; 2022 Nov; 27(6):e13232. PubMed ID: 36301211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma Markers of Neurodegeneration Are Raised in Friedreich's Ataxia.
    Zeitlberger AM; Thomas-Black G; Garcia-Moreno H; Foiani M; Heslegrave AJ; Zetterberg H; Giunti P
    Front Cell Neurosci; 2018; 12():366. PubMed ID: 30425621
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatic and renal function impact concentrations of plasma biomarkers of neuropathology.
    Berry K; Asken BM; Grab JD; Chan B; Lario Lago A; Wong R; Seetharaman S; LaHue SC; Possin KL; Rojas JC; Kramer JH; Boxer AL; Lai JC; VandeVrede L
    Alzheimers Dement (Amst); 2022; 14(1):e12321. PubMed ID: 35845260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Levels of NfL, GFAP, TAU, and UCH-L1 as Potential Predictor Biomarkers of Severity and Lethality in Acute COVID-19.
    Salvio AL; Fernandes RA; Ferreira HFA; Duarte LA; Gutman EG; Raposo-Vedovi JV; Filho CHFR; da Costa Nunes Pimentel Coelho WL; Passos GF; Andraus MEC; da Costa Gonçalves JP; Cavalcanti MG; Amaro MP; Kader R; de Andrade Medronho R; Figueiredo CP; Amado-Leon LA; Alves-Leon SV
    Mol Neurobiol; 2024 Jun; 61(6):3545-3558. PubMed ID: 37996731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of plasma levels of NFL, GFAP, UCHL1 and tau as Parkinson's disease biomarkers using multiplexed single molecule counting.
    Youssef P; Hughes L; Kim WS; Halliday GM; Lewis SJG; Cooper A; Dzamko N
    Sci Rep; 2023 Mar; 13(1):5217. PubMed ID: 36997567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated evaluation of a panel of neurochemical biomarkers to optimize diagnosis and prognosis in amyotrophic lateral sclerosis.
    Falzone YM; Domi T; Mandelli A; Pozzi L; Schito P; Russo T; Barbieri A; Fazio R; Volontè MA; Magnani G; Del Carro U; Carrera P; Malaspina A; Agosta F; Quattrini A; Furlan R; Filippi M; Riva N
    Eur J Neurol; 2022 Jul; 29(7):1930-1939. PubMed ID: 35263489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex Differences in Behavioral Symptoms and the Levels of Circulating GFAP, Tau, and NfL in Patients With Traumatic Brain Injury.
    Sass D; Guedes VA; Smith EG; Vorn R; Devoto C; Edwards KA; Mithani S; Hentig J; Lai C; Wagner C; Dunbar K; Hyde DR; Saligan L; Roy MJ; Gill J
    Front Pharmacol; 2021; 12():746491. PubMed ID: 34899299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Tau, Neurofilament Light Chain, Glial Fibrillary Acidic Protein, and Ubiquitin Carboxyl-Terminal Hydrolase L1 Are Associated with the Chronic Deterioration of Neurobehavioral Symptoms after Traumatic Brain Injury.
    Lange RT; Lippa S; Brickell TA; Gill J; French LM
    J Neurotrauma; 2023 Mar; 40(5-6):482-492. PubMed ID: 36170576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged elevation of serum neurofilament light after concussion in male Australian football players.
    McDonald SJ; O'Brien WT; Symons GF; Chen Z; Bain J; Major BP; Costello D; Yamakawa G; Sun M; Brady RD; Mitra B; Mychasiuk R; O'Brien TJ; Shultz SR
    Biomark Res; 2021 Jan; 9(1):4. PubMed ID: 33422120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum glial fibrillary acidic protein is a predictor of brain metastases in patients with metastatic breast cancer.
    Darlix A; Hirtz C; Mollevi C; Ginestet N; Tiers L; Jacot W; Lehmann S
    Int J Cancer; 2021 Oct; 149(8):1605-1618. PubMed ID: 34196964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma neurofilament light chain and glial fibrillary acidic protein predict stroke in CADASIL.
    Chen CH; Cheng YW; Chen YF; Tang SC; Jeng JS
    J Neuroinflammation; 2020 Apr; 17(1):124. PubMed ID: 32321529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time course and diagnostic utility of NfL, tau, GFAP, and UCH-L1 in subacute and chronic TBI.
    Shahim P; Politis A; van der Merwe A; Moore B; Ekanayake V; Lippa SM; Chou YY; Pham DL; Butman JA; Diaz-Arrastia R; Zetterberg H; Blennow K; Gill JM; Brody DL; Chan L
    Neurology; 2020 Aug; 95(6):e623-e636. PubMed ID: 32641529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient Changes in the Plasma of Astrocytic and Neuronal Injury Biomarkers in COVID-19 Patients without Neurological Syndromes.
    Lennol MP; Ashton NJ; Moreno-Pérez O; García-Ayllón MS; Ramos-Rincon JM; Andrés M; León-Ramírez JM; Boix V; Gil J; Blennow K; Merino E; Zetterberg H; Sáez-Valero J
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurofilament light, glial fibrillary acidic protein, and tau in a regional epilepsy cohort: High plasma levels are rare but related to seizures.
    Akel S; Asztely F; Banote RK; Axelsson M; Zetterberg H; Zelano J
    Epilepsia; 2023 Oct; 64(10):2690-2700. PubMed ID: 37469165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum GFAP, NfL, and tau concentrations are associated with worse neurobehavioral functioning following mild, moderate, and severe TBI: a cross-sectional multiple-cohort study.
    Edwards KA; Lange RT; Lippa SM; Brickell TA; Gill JM; French LM
    Front Neurol; 2023; 14():1223960. PubMed ID: 38292036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum total tau, neurofilament light, and glial fibrillary acidic protein are associated with mortality in a population study.
    Halloway S; Evans DA; Desai P; Dhana K; Beck T; Rajan KB
    J Am Geriatr Soc; 2024 Jan; 72(1):149-159. PubMed ID: 37818793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined GFAP, NFL, Tau, and UCH-L1 panel increases prediction of outcomes in neonatal encephalopathy.
    Yang Z; Xu H; Sura L; Arja RD; Patterson RL; Rossignol C; Albayram M; Rajderkar D; Ghosh S; Wang K; Weiss MD
    Pediatr Res; 2023 Apr; 93(5):1199-1207. PubMed ID: 35273370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers for central nervous system injury in cerebrospinal fluid are elevated in COVID-19 and associated with neurological symptoms and disease severity.
    Virhammar J; Nääs A; Fällmar D; Cunningham JL; Klang A; Ashton NJ; Jackmann S; Westman G; Frithiof R; Blennow K; Zetterberg H; Kumlien E; Rostami E
    Eur J Neurol; 2021 Oct; 28(10):3324-3331. PubMed ID: 33369818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of five clinically important neuroglial proteins in the human brain.
    Sjölin K; Kultima K; Larsson A; Freyhult E; Zjukovskaja C; Alkass K; Burman J
    Mol Brain; 2022 Jun; 15(1):52. PubMed ID: 35765081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.